TickerFacts.

Company research / MMSI

Merit Medical Systems Inc (MMSI)

Build a valuation ↗↓ Download CSV

SEC name MERIT MEDICAL SYSTEMS INC · CIK 0000856982 · Nasdaq · Surgical & Medical Instruments & Apparatus

  • Sector Manufacturing
  • Incorporated UT
  • Fiscal year ends Dec 31

For the year ended 2025-12-31, Merit Medical Systems Inc reported revenue of $1.52B. Revenue grew 11.8% from the prior annual period. Over the twelve months to 2026-06-30, revenue was $1.58B.

Key ratios (year ended 2025-12-31)

48.7%
Gross margin
12.2%
Operating margin
8.5%
Net margin
8.1%
Return on year-end equity
11.8%
Revenue growth (YoY)

Beyond the statements

Follow the company.

Explore new filings, reported insider transactions and company relationships.

Open company research ↗

Latest selected filing: Form 4 (ownership change) · 2026-09-09

Annual financials

Annual flows and balances are grouped by their actual period end. Select a figure to open its SEC filing. n/a means a matching observation is unavailable. Free cash flow is operating cash flow minus capital expenditures, and EBITDA is operating income plus depreciation and amortization, for the same period, computed by TickerFacts.

The first column covers the twelve months to 2026-06-30 from the latest quarterly report: flows are the last fiscal year plus this year to date minus the same months a year earlier, and balances are as of that date. Per-share figures are annual only.

Period endedTTM to
2026-06-30		2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-31
Revenue$1.58B$1.52B$1.36B$1.26B$1.15B$1.07B$963.88M$994.85M$882.75M$727.85M$603.84M
Cost of Revenue$797.09M$777.64M$713.18M$673.49M$631.88M$589.42M$562.70M$562.49M$487.98M$401.60M$338.81M
Gross Profit$781.73M$738.27M$643.33M$583.87M$519.10M$485.33M$401.18M$432.37M$394.77M$326.25M$265.02M
R&D Expense$98.50M$97.35M$87.47M$82.73M$75.51M$71.25M$57.54M$65.61M$59.53M$51.40M$45.23M
Operating Income$201.37M$184.72M$155.69M$123.94M$87.56M$60.92M-$1.56M$15.43M$58.62M$33.07M$34.88M
Depreciation & Amortization$124.39M$123.17M$102.71M$89.98M$81.80M$84.07M$94.07M$92.10M$69.55M$53.58M$43.76M
EBITDA$325.76M$307.89M$258.40M$213.93M$169.37M$144.98M$92.51M$107.53M$128.16M$86.65M$78.63M
Net Income$145.56M$128.49M$120.36M$94.41M$74.52M$48.45M-$9.84M$5.45M$42.02M$27.52M$20.12M
EPS (Diluted)n/a$2.13$2.03$1.62$1.29$0.84-$0.18$0.10$0.78$0.55$0.45
Total Assets$2.86B$2.69B$2.42B$2.33B$1.66B$1.65B$1.66B$1.76B$1.62B$1.11B$942.80M
Total Liabilities$1.18B$1.10B$1.04B$1.12B$519.57M$608.50M$705.82M$807.38M$687.24M$435.48M$444.61M
Long-Term Debt$736.26M$734.04M$729.55M$823.01M$198.01M$242.84M$351.22M$439.48M$395.15M$278.47M$324.37M
Shareholders' Equity$1.68B$1.58B$1.38B$1.20B$1.14B$1.04B$958.58M$949.94M$932.77M$676.33M$498.19M
Cash & Equivalents$448.70M$446.40M$376.71M$587.04M$58.41M$67.75M$56.92M$44.32M$67.36M$32.34M$19.17M
Operating Cash Flow$283.45M$297.37M$220.80M$145.15M$114.29M$147.23M$165.27M$77.81M$86.53M$62.73M$53.60M
Capital Expenditures$80.24M$81.72M$35.14M$34.29M$45.03M$27.94M$45.99M$78.17M$63.32M$38.62M$32.84M
Free Cash Flow$203.21M$215.66M$185.66M$110.86M$69.26M$119.29M$119.28M-$360.0K$23.21M$24.10M$20.76M
Shares Outstanding59.71M59.42M58.74M57.86M57.31M56.57M55.62M55.21M54.89M50.25M44.65M
Weighted Average Diluted Sharesn/a60.46M59.37M58.36M57.67M57.36M55.43M56.23M53.93M50.10M44.86M
EPS (Basic)n/a$2.17$2.07$1.64$1.31$0.86-$0.18$0.10$0.80$0.56$0.45

Price chart

Chart and quotes by TradingView. Exchange coverage and delays vary.

Open chart on TradingView